【摘要】 目的:探讨在脂肪肝治疗中联合使用YB-ZG肝病治疗仪治疗的临床效果。方法:采用临床随机分组对照试验方法。对照组30例,采用常规治疗;试验组31例,在常规治疗基础上加用YB-ZG肝病治疗仪治疗,每日1次,每次30min,30d为1个疗程。分别于治疗前、治疗后及随访1个月观察临床主要症状,检测肝功能及血脂。结果:①试验组治疗后的胁肋疼痛、脘腹胀满、恶心嗳气评分及总积分均较对照组有明显缓解(均P<0.05);②试验组治疗后γ谷氨酰转肽酶(GGT)的有效率(75.0％)、复常率(57.1％)及检测值的总体水平[(46.3±25.4)U/L]均明显优于对照组[42.9％、25.0％、(63.2±23.9)U/L],而且在随访期仍能持续保持(均P<0.05);③试验组谷丙转氨酶(ALT)、谷草转氨酶(AST)的复常率(51.6％、53.8％)均明显高于对照组(23.3％、23.1％)(均P<0.05)。随访时总胆固醇检测值的总体水平试验组[(5.23±0.82)mmol/L]与对照组[(5.55±0.34)mmol/L]比较,差异有显著性意义(P<0.05)。结论:脂肪肝治疗中联合使用YB-ZG肝病治疗仪治疗能有助于提高临床疗效。更多还原

【Abstract】 Objective: To evaluate the effect of ordinary therapy combined with YB-ZG Liver Disease Therapy Instrument on patients with fatty liver. Methods: Sixty-one patients with fatty liver were randomi2ed into control group ( n = 30, using ordinary therapy) and therapy instrument group ( n =31, using ordinary therapy combined with YB-ZG Liver Disease Therapy Instrument). The main symptoms, ALT, AST, GGT, TC and TG were measured in all patients before treatment, at the end of the 1st month (instrument therapy) and at the end of the 2nd month (follow-up visit). Results : After the instrument therapy for 1 month: ① the value of pain in right side rib area, abdominal discomfort, nausea and the sum of symptoms (Median = 0, 0, 0, 4) in therapy instrument group were statistically significantly lower ( P <0. 05) than those(2, 2, 0, 8) in control group; ② the effective rate (75. 0%), normalization rate (57. 1%) and serum level [Mean±SD= (46. 3±25. 4)U/ L] of GGT in therapy instrument group were significantly higher ( P <0. 05) than those [42. 9%, 25. 0% ,(63. 2±23. 9)U/L] in control group, and the differences remained during follow-up visit; ③ the normalization rates (51. 6%, 53. 8%) of ALT, AST in therapy instrument group were significantly higher ( P <0. 05) than those (23. 3 %, 23. 1 %) in control group. During follow-up visit, the serum level (5. 23 ±0. 82)mmol/L of TC in therapy instrument group was significantly lower ( P <0. 05) than that (5. 55±0. 34)mmol/L in control group. Conclusion: Applying YB-ZG Liver Disease Therapy Instrument in the treatment was benefit to the patients with fatty liver.更多还原